|
BLOC1S1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.15439999676315E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.48579999970089E-07 |
| Normal-vs-Stage2 |
6.978100E-02 |
| Normal-vs-Stage3 |
1.901000E-01 |
| Normal-vs-Stage4 |
4.296600E-01 |
| Stage1-vs-Stage2 |
5.622000E-01 |
| Stage1-vs-Stage3 |
1.047430E-01 |
| Stage1-vs-Stage4 |
4.224800E-01 |
| Stage2-vs-Stage3 |
4.218200E-01 |
| Stage2-vs-Stage4 |
7.363400E-01 |
| Stage3-vs-Stage4 |
8.188400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.71390000034155E-07 |
| Normal-vs-AfricanAmerican |
4.758100E-04 |
| Normal-vs-Asian |
7.562500E-02 |
| Caucasian-vs-AfricanAmerican |
2.047000E-01 |
| Caucasian-vs-Asian |
6.551000E-01 |
| AfricanAmerican-vs-Asian |
1.147170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.11930001220639E-09 |
| Normal-vs-Female |
6.653800E-02 |
| Male-vs-Female |
2.492100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.776200E-03 |
| Normal-vs-Extreme_Weight |
2.43430000046452E-07 |
| Normal-vs-Obese |
9.242800E-03 |
| Normal-vs-Extreme_Obese |
1.520590E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.797600E-01 |
| Normal_Weight-vs-Obese |
5.062200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.205000E-01 |
| Extreme_Weight-vs-Obese |
9.911700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.858000E-01 |
| Obese-vs-Extreme_Obese |
8.701200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.013200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.35430000000192E-05 |
| Normal-vs-Age(61-80Yrs) |
9.33259999946756E-07 |
| Normal-vs-Age(81-100Yrs) |
1.945190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.809200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.052600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.227600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.256400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.110000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.245400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.53860257867677E-11 |
| Normal-VS-Type2 PRCC |
6.782000E-02 |
| Normal-VS-KIRP CIMP |
8.402700E-03 |
| Normal-VS-Unclassified PRCC |
1.382820E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.442400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.85869999997013E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
8.587600E-04 |
| Type2 PRCC-VS-KIRP CIMP |
6.658700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.352600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.918000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.816800E-04 |
| Normal-vs-N1 |
8.599800E-01 |
| Normal-vs-N2 |
2.970200E-01 |
| N0-vs-N1 |
2.272200E-02 |
| N0-vs-N2 |
8.271400E-01 |
| N1-vs-N2 |
3.067800E-01 |
|
|
